Full Press Release Details
NEW YORK, NY--(Marketwire - July 23, 2007) - Daxor Corporation (AMEX: DXR), a medical
instrumentation and biotechnology company, today announced the publication
of a symposium issue on blood volume and blood volume measurement in the
American Journal of the Medical Sciences. This is the first symposium on
blood volume in clinical medicine to be published in 20 years. The American
Journal of the Medical Sciences, founded in 1820, is the second oldest
medical journal in the United States and is the official journal of the
Southern Society for Clinical Investigation.
The symposium contains ten articles related to blood volume measurement.
Six articles, including two original research articles, include or discuss
data obtained by researchers utilizing the Daxor BVA-100 semi-automated
Blood Volume Analyzer.
Satish Raj, MD, MSCI, and David Robertson, MD, researchers at the
Vanderbilt University School of Medicine in Nashville, TN, edited the
In their introductory editorial, "Blood volume assessment in clinical
medicine: the phoenix has arisen," they state: "Development of methods for
indirect blood volume assessment yielded a productive period of
investigation in the mid-20th century. Differences in blood volume were
noted in many disease processes. It was difficult for blood volume
determinations, however, to make the leap from clinical investigation to
clinical practice, owing to the relative difficulty of carrying out the
techniques. That difficulty has now receded somewhat with the availability
of more convenient methods. This is fueling a resurgence of interest and
discovery in this field.
"The blood volume phoenix has clearly arisen. A new intensity of
investigation in management of heart failure, syncope, syndromes of
orthostatic intolerance, and other conditions is currently emerging. It has
been some 20 years since the last symposium on blood volume in clinical
medicine appeared. That encouraged us to bring in expertise from a variety
of disciplines to summarize where the field of blood volume is at this
The articles related to the BVA-100 cover topics such as blood volume
measurement technology and the roles of blood volume in heart failure,
syncope, and orthostatic intolerance. They include:
"Techniques used for the determination of blood volume" by Andrew Ertl,
Andre Diedrich, and Satish Raj, from Vanderbilt University School of
Medicine in Nashville, TN.
"Comparison of red cell and whole blood volume as performed using both
chromium-51-tagged red cells and
iodine-125-tagged albumin and using
I-131-tagged albumin and extrapolated red cell volume" by Howard Dworkin,
Mary Premo, and Stuart Dees, from William Beaumont Hospital in Royal Oak,
"The importance of correct norms in blood volume measurements" by Joseph
Feldschuh and Stuart Katz, from, respectively, Daxor Corporation in NY, NY,
and Yale University in New Haven, CT.
"Blood volume assessment in the diagnosis and treatment of chronic heart
failure" by Stuart Katz, from Yale University in New Haven, CT.
"Blood volume measurement as a tool in diagnosing syncope" by
Fetnat Fouad-Tarazi, et al., from the Cleveland Clinic in Cleveland, OH.
"Blood volume perturbations in the postural tachycardia syndrome" by Satish
Raj and David Robertson, from Vanderbilt University School of Medicine in
The other articles cover topics including the sympathetic nervous system's
and the kidneys' roles in blood volume regulation, the response of blood
volume to physical activity and inactivity, and changes in the blood volume
during space travel. Abstracts of these articles can be found on the
journal's website, www.amjmedsci.com.
Daxor Corporation manufactures and markets the BVA-100, a semi-automated
Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex,
Daxor's single use diagnostic kit. For more information regarding Daxor
Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website
Contact Information: Contact Information:
Chief Operating Officer